Showing results (151-160 of 186) with videos related to
Sort By:
Pageof 19
Pharmacoepidemiology and Drug Safety|June 4, 2014
Estimating the incremental net health benefit of requirements for cardiovascular risk evaluation for diabetes therapiesAnita J Chawla, Daniel S Mytelka, Stephan D McBride, et al.The Journal of Infectious Diseases|June 14, 2011
Assessing the cost-effectiveness of measles elimination in Uganda: local impact of a global eradication programJoseph B Babigumira, Ann Levin, Colleen Burgess, et al.Neurology and Therapy|September 18, 2024
Estimating the Economically Justifiable Price of Limited-Duration Treatment with Donanemab for Early Symptomatic Alzheimer's Disease in the United StatesMalaz Boustani, Erin G Doty, Louis P Garrison, et al.Journal of Managed Care & Specialty Pharmacy|December 27, 2021
Health care costs and resource utilization among commercially insured adult patients with hemophilia A managed with FVIII prophylaxis in the United StatesCourtney D Thornburg, Kelly Adamski, Keziah Cook, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 5, 2021
Concern about addiction is associated with lower quality of life in patients with osteoarthritis: an exploratory, real-world data analysisLouis P Garrison, Patricia Schepman, Andrew G Bushmakin, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 31, 2009
Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part IJoel W Hay, Jim Smeeding, Norman V Carroll, et al.Vaccines|November 27, 2021
The Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in Seven Chinese CitiesYan Li, Huaqing Wang, Wesley Furnback, et al.Journal for Immunotherapy of Cancer|July 15, 2020
Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspectiveCasey Quinn, Louis P Garrison, Anja K Pownell, et al.Current Medical Research and Opinion|January 12, 2011
Exenatide bid observational study (ExOS): baseline population characteristics of a prospective research study to evaluate the clinical effectiveness of exenatide bid use in patients with type 2 diabetes in a real-world settingRichard M Bergenstal, Louis P Garrison, Matthew Wintle, et al.Clinical Therapeutics|October 9, 2022
Assessing the Cost-effectiveness of a Hypothetical Disease-modifying Therapy With Limited Duration for the Treatment of Early Symptomatic Alzheimer DiseaseMalaz Boustani, Erin G Doty, Louis P Garrison, et al.Pageof 19